肥胖杂志

肥胖杂志/2020年/文章/标签4

研究文章

体重变化及其与代谢疾病风险标记在超重和肥胖的妇女

表4

意味着改变代谢疾病风险因素的类别减肥在维护阶段。

代谢疾病风险标记 维护阶段(6至12个月)
控制 干预
> 2%的涨幅 ±2%的维护 > 2 - < 5%的损失 5 - 20%的损失 价值 > 2%的涨幅 ±2%的维护 > 2 - < 5%的损失 5 - 20%的损失 价值
n= 44 n= 45 n= 16 n= 9 n= 49 n= 57 n= 13 n= 10

WC,厘米 1.05 −1.09 −4.67一个 −1.37 0.001 0.26 −0.69 −4.59一个 −3.26 0.008
(−0.32,2.42) (−2.44,0.26) (−7.00−2.35) (−4.59,1.85) (−1.13,1.66) (−1.98,0.60) (−7.31−1.88) (−6.41−0.11)
台塑,更易与L 0.17 −0.21 −0.57 0.40 0.003 −0.07 −0.24 −0.31 −0.30 0.584
(−0.11,0.46) (−0.48,0.07) (−1.05−0.09) (−0.26,1.05) (−0.29,0.14) (−0.44−0.04) (−0.74,0.11) (−0.78,0.19)
空腹胰岛素,μU /毫升 1.20 2.10 −1.33 1.26 0.619 1.30 −0.60 0.22 3.74 0.375
(−1.15,3.56) (−0.18,4.38) (−6.01,3.34) (−4.31,6.83) (−0.85,3.44) −2.57,1.38) (−3.83,4.26) (−1.92,9.40)
HOMA-IR 0.23 0.47 0.04 −0.24 0.813 0.36 0.31 0.60 −0.61 0.707
(−0.51,0.97) (−0.17,1.11) (−1.35,1.43) (−1.81,1.33) (−0.31,1.04) (−0.32,0.95) (−0.67,1.87) (−2.25,1.04)
甘油三酯,更易与L 0.10 −0.16 0.04 −0.35 0.207 −0.04 −0.18 −0.09 0.13 0.527
(−0.11,0.31) (−0.37,0.05) (−0.32,0.40) (−0.85,0.15) (−0.24,0.15) (−0.36,0.00) (−0.47,0.29) (−0.31,0.57)
TC,更易与L 0.30 0.22 0.26 −0.26 0.414 −0.07 −0.01 −0.33 0.19 0.493
(0.04,0.55) (−0.03,0.47) (−0.18,0.70) (−0.86,0.34) (−0.30,0.16) (−0.22,0.20) (−0.77,0.12) (−0.32,0.70)
高密度脂蛋白胆固醇,更易与L 0.06 −0.07 −0.09 −0.14 0.018 −0.03 −0.04 −0.12 −0.07 0.521
(−0.01,0.12) (−0.13−0.00) (−0.21,0.03) (−0.30,0.02) (−0.08,0.03) (−0.09,0.01) (−0.22−0.01) (−0.20,0.05)
低密度,更易与L −0.16 −0.46 −0.45 −0.99 0.051 −0.34 −0.34 −0.89 0.35 0.251
(−0.41,0.09) (−0.71−0.22) (−0.88,0.02) (−1.58,0.40) (−0.56−0.12) (−0.55−0.14) (−1.32−0.47) (−0.14,0.83)
肿瘤坏死因子-αpg / mL −5.93 −6.57 −11.60 −7.11 0.050 −6.93 −6.72 −5.50 −6.05 0.939
(−7.75−4.11) (−8.13−5.00) (−15.5−8.05) (−12.45−1.65) (−8.98−4.87) (−8.68−4.76) (−9.73−1.25) (−15.00−2.91)
脂联素,μ克/毫升 −0.41 0.89 0.26 0.75 0.886 0.47 −0.91 0.67 1.10 0.287
(−1.45,0.62) (0.00,1.78) (−1.76,2.27) (−2.33,3.82) (−0.68点) (−1.99,0.17) (−1.68,3.03) (−3.74,5.94)
Hs-CRP,μ克/毫升 0.90 −0.30 −1.99 7.27 0.071 −0.08 2.54 2.89 2.59 0.166
(−1.11,12.90) (−2.03,1.42) (−5.91,1.93) (1.31,13.23) (−1.86,1.70) (0.86,4.22) (−0.73,6.51) (−4.86,10.03)

请注意。数据作为估计边际的意思(95% CI)。一个显著差异相对于> 2%体重增加。b显著差异相对于±2%的体重。 参与者的数量的胰岛素、HOMA-IR和炎症标记物如下:胰岛素。反对:> 2%:40±2%维护:42岁> 2 - < 5%的损失:11和5 - 20%的损失:8。INT > 2%: 46岁的±2%维护:52岁> 2 - < 5%的损失:13 - 5 - 20%的损失:8。HOMA-IR。反对:> 2%:31日±2%维护:41岁> 2 - < 5%的损失:10到5 - 20%的损失:8。INT > 2%: 46岁的±2%维护:52岁> 2 - < 5%的损失:13 - 5 - 20%的损失:8。炎症标记物。反对:> 2%:25±2%维护:34岁> 2 - < 5%的损失:7和5 - 20%的损失:3。INT > 2%: 33岁的±2%维护:37岁> 2 - < 5%的损失:8 - 5 - 20%的损失:2。

文章奖:2020年杰出的研究贡献,选择由我们的首席编辑。获奖的文章阅读